# Nuveen Real Estate Income Fund: filings

JRS · NYSE · CIK 1158289 · [Other](/sectors/other.md)

Pages: [Overview](/companies/jrs.md) · [Financials](/companies/jrs/financials.md) · [Filings](/companies/jrs/filings.md) · [Insiders](/companies/jrs/insiders.md)

## Reports and events: 22 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (3 44, NPORT-P 28, N-Q 20, DEF 14A 18, N-CSR 18, N-CSRS 18, N-PX 18, 4 14, NSAR-B 10, NSAR-A 9, N-CEN 8, 8-K 4, 40-APP/A 3, DEFA14A 3, PRE 14A 3, SC 13G/A 3, N-23C-2 2, 25 1, 3/A 1, 40-APP 1, 497 1, 8-A12B 1, APP NTC 1, APP ORDR 1, CERTNYS 1, EFFECT 1, N-2 1, N-2/A 1, NPORT-EX 1, PRER14A 1, SC 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-03-04 | 17:31 ET | [DEF 14A](/filings/0001193125-26-088857.md) | Proxy statement, period 2026-04-16 | 0001193125-26-088857 |
| 2025-03-04 | 17:22 ET | [DEF 14A](/filings/0001193125-25-045740.md) | Proxy statement, period 2025-04-17 | 0001193125-25-045740 |
| 2024-03-06 | 15:05 ET | [8-K](/filings/0001193125-24-060596.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-060596 |
| 2024-02-27 | 15:56 ET | [DEF 14A](/filings/0001193125-24-047885.md) | Proxy statement, period 2024-04-12 | 0001193125-24-047885 |
| 2023-10-13 | 07:16 ET | [8-K](/filings/0001193125-23-255673.md) | 5.02 Departure or appointment of officers or directors | 0001193125-23-255673 |
| 2023-03-30 | 11:09 ET | [DEF 14A](/filings/0001193125-23-084823.md) | Proxy statement, period 2023-05-08 | 0001193125-23-084823 |
| 2022-02-25 | 06:43 ET | [8-K](/filings/0001193125-22-053137.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-053137 |
| 2022-02-24 | 17:18 ET | [DEF 14A](/filings/0001193125-22-052411.md) | Proxy statement, period 2022-04-08 | 0001193125-22-052411 |
| 2021-03-04 | 13:14 ET | [DEF 14A](/filings/0001193125-21-069126.md) | Proxy statement, period 2021-04-06 | 0001193125-21-069126 |
| 2020-10-06 | 19:43 ET | [8-K](/filings/0001193125-20-264115.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-20-264115 |
| 2020-03-02 | 16:38 ET | [DEF 14A](/filings/0001193125-20-059039.md) | Proxy statement, period 2020-04-08 | 0001193125-20-059039 |
| 2019-02-26 | 12:25 ET | [DEF 14A](/filings/0001193125-19-051492.md) | Proxy statement, period 2019-04-10 | 0001193125-19-051492 |
| 2018-02-23 | 17:24 ET | [DEF 14A](/filings/0001193125-18-056214.md) | Proxy statement, period 2018-04-11 | 0001193125-18-056214 |
| 2017-02-24 | 17:16 ET | [DEF 14A](/filings/0001193125-17-056558.md) | Proxy statement, period 2017-04-06 | 0001193125-17-056558 |
| 2016-03-10 | 16:26 ET | [DEF 14A](/filings/0001193125-16-500177.md) | Proxy statement, period 2016-04-22 | 0001193125-16-500177 |
| 2015-02-17 | 17:07 ET | [DEF 14A](/filings/0001258897-15-001435.md) | Proxy statement, period 2015-03-26 | 0001258897-15-001435 |
| 2014-06-19 | 17:24 ET | [DEF 14A](/filings/0001193125-14-242583.md) | Proxy statement, period 2014-08-05 | 0001193125-14-242583 |
| 2013-02-28 | 10:35 ET | [DEF 14A](/filings/0001193125-13-082597.md) | Proxy statement, period 2013-04-03 | 0001193125-13-082597 |
| 2012-03-01 | 16:31 ET | [DEF 14A](/filings/0001193125-12-092263.md) | Proxy statement, period 2012-03-30 | 0001193125-12-092263 |
| 2011-03-30 | 14:10 ET | [DEF 14A](/filings/0000950123-11-030709.md) | Proxy statement, period 2011-05-06 | 0000950123-11-030709 |
| 2010-02-26 | 06:07 ET | [DEF 14A](/filings/0000950123-10-017407.md) | Proxy statement, period 2010-04-06 | 0000950123-10-017407 |
| 2009-04-02 | 15:35 ET | [DEF 14A](/filings/0000950137-09-002534.md) | Proxy statement, period 2009-05-06 | 0000950137-09-002534 |

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:05 ET. No prices; not investment advice.